Radiopharmaceutical Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2024

May 2018| TMR570A| Transparency

Report Highlights

Radiopharmaceutical Market: Scope and Trends

This report on the radiopharmaceutical market analyzes the current and future scenario of the global market. Increase in incidence of various diseases, development of new sources for radioisotope production, and rise in demand for nuclear medicine are boosting the radiopharmaceutical market. Increase in incidence of cancer and cardiovascular diseases, growth in awareness about effective use of radiopharmaceuticals, and rise in preference for SPECT and PET scans are some of the factors expected to drive the growth of the global radiopharmaceutical market during the forecast period.

The radiopharmaceutical market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on radioisotopes, source, end-user, and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises Porters Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global radiopharmaceutical market.

Radiopharmaceutical Market: Segmentation

Based on radioisotope, the market has been segmented into Technetium-99, Lutetium-177, Rubidium-87, Iodine-123, Yttrium-90, and Gallium-62. Technetium-99 is the most widely used radioisotope across the globe; around 70% of radiopharmaceutical companies depend on Mo-99 to produce Technetium-99, as per the World Nuclear Association. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference for technological systems by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2017 to 2024, considering 2016 as the base year.

Based on source, the radiopharmaceutical market has been segmented into two major categories: nuclear reactors and cyclotrons. The market segments have been extensively analyzed based on increase in demand for radioisotopes for nuclear medicines, availability of radioisotopes and raw materials, radioisotopes short half-life and number of production units used for production of radioisotopes. Different types of end-user utilize radiopharmaceutical products to treat diseases either through imaging techniques or the therapeutics method.

Under the end-user segment, hospitals plays a major role followed by ambulatory surgical centers, diagnostic centers, and others (such as universities, research laboratories, and pathology labs). The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2024, considering 2016 as the base year. Application segment signifies the usage of radiopharmaceutical products through different disease indication such as oncology, cardiology, neurology, nephrology, gastroenterology, immunology and others. Oncology segment is the dominant sector which emphasizes the use of different radioisotopes for treating various cancers and overcome the side effects of therapeutics. Brachytherapy is a sub segment of oncology application which signifies the methods of treating cancer through implants, surgery or radiation technology. The segment is expected to have a significant growth during the forecast period.

Geographically, the global radiopharmaceutical market has been categorized into five major regions and the key countries in the respective region: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, Japan, China, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, Saudi Arabia, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2017 to 2024, considering 2016 as the base year.

Radiopharmaceutical Market: Competitive Landscape

The report also profiles major players in the global radiopharmaceutical market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Advanced Accelerator Applications (AAA), Eckert & Ziegler, GE Healthcare, IBA Radiopharma Solutions, Lantheus Holdings, Inc., Mallinckrodt PLC, Nordion, Inc., Siemens Healthineers, and Positron Corporation.

Key Segments of the Global Radiopharmaceuticals Market

By Radioisotope

Technetium-99
Gallium-67
Iodine-123
18F
Rubidium-82
Yttrium-90
Lutetium-177
By Source

Nuclear Reactors
Cyclotrons
By End-user

Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
By Application

Cardiology
Gastroenterology
Oncology
Brachytherapy
Others
Nephrology
Neurology
Immunology
Others
By Region and Country

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

  • Table 1 : Global Radiopharmaceutical Market Size (US$ Mn) Forecast, by Radioisotope, 2014–2024
  • Table 2 : Global Radiopharmaceutical Market Size (US$ Mn) Forecast, by Source, 2014–2024
  • Table 3 : Global Radiopharmaceutical Market Size (US$ Mn) Forecast, by Application, 2014–2024
  • Table 4 : Global Radiopharmaceutical Market Size (US$ Mn) Forecast, by Oncology Application, 2014–2024
  • Table 5 : Global Radiopharmaceutical Market Size (US$ Mn) Forecast, by End-user, 2014–2024
  • Table 6 : Global Radiopharmaceutical Market Size (US$ Mn) Forecast, by Region, 2014–2024
  • Table 7 : North America Radiopharmaceutical Market Size (US$ Mn) Forecast, By Country, 2014–2024
  • Table 8 : North America Radiopharmaceutical Market Size (US$ Mn) Forecast, by Radioisotope, 2014–2024
  • Table 9 : North America Radiopharmaceutical Market Size (US$ Mn) Forecast, by Source, 2014–2024
  • Table 10 : North America Radiopharmaceuticals Market Size (US$ Mn) Forecast, by Application, 2014–2024
  • Table 11 : North America Radiopharmaceuticals Market Size (US$ Mn) Forecast, by Oncology Application, 2014–2024
  • Table 12 : North America Radiopharmaceutical Market Size (US$ Mn) Forecast, by End-user, 2014–2024
  • Table 13 : Europe Radiopharmaceutical Market Size (US$ Mn) Forecast, by Country, 2014–2024
  • Table 14 : Europe Radiopharmaceutical Market Size (US$ Mn) Forecast, by Radioisotope, 2014–2024
  • Table 15 : Europe Radiopharmaceutical Market Size (US$ Mn) Forecast, by Source, 2014–2024
  • Table 16 : Europe Radiopharmaceuticals Market Size (US$ Mn) Forecast, by Application, 2014–2024
  • Table 17 : Europe Radiopharmaceuticals Market Size (US$ Mn) Forecast, by Oncology Application, 2014–2024
  • Table 18 : Europe Radiopharmaceutical Market Size (US$ Mn) Forecast, by End-user, 2014–2024
  • Table 19 : Asia Pacific Radiopharmaceutical Market Size (US$ Mn) Forecast, by Country, 2014–2024
  • Table 20 : Asia Pacific Radiopharmaceutical Market Size (US$ Mn) Forecast, by Radioisotope, 2014–2024
  • Table 21 : Asia Pacific Radiopharmaceutical Market Size (US$ Mn) Forecast, by Source, 2014–2024
  • Table 22 : Asia Pacific Radiopharmaceutical Market Size (US$ Mn) Forecast, by Application, 2014–2024
  • Table 23 : Asia Pacific Radiopharmaceutical Market Size (US$ Mn) Forecast, by Oncology Application, 2014–2024
  • Table 24 : Asia Pacific Radiopharmaceutical Market Size (US$ Mn) Forecast, by End-user, 2014–2024
  • Table 25 : Latin America Radiopharmaceutical Market Size (US$ Mn) Forecast, by Country, 2014–2024
  • Table 26 : Asia Pacific Radiopharmaceutical Market Size (US$ Mn) Forecast, by Radioisotope, 2014–2024
  • Table 27 : Latin America Radiopharmaceutical Market Size (US$ Mn) Forecast, by Source, 2014–2024
  • Table 28 : Latin America Radiopharmaceutical Market Size (US$ Mn) Forecast, by Application, 2014–2024
  • Table 29 : Latin America Radiopharmaceutical Market Size (US$ Mn) Forecast, by Oncology Application, 2014–2024
  • Table 30 : Latin America Radiopharmaceutical Market Size (US$ Mn) Forecast, by End-user, 2014–2024
  • Table 31 : Middle East & Africa Radiopharmaceutical Market Size (US$ Mn) Forecast, by Country, 2014–2024
  • Table 32 : Asia Pacific Radiopharmaceutical Market Size (US$ Mn) Forecast, by Radioisotope, 2014–2024
  • Table 33 : Middle East & Africa Radiopharmaceutical Market Size (US$ Mn) Forecast, by Source, 2014–2024
  • Table 34 : Middle East and Africa Radiopharmaceutical Market Size (US$ Mn) Forecast, by Application, 2014–2024
  • Table 35 : Middle East and Africa Radiopharmaceutical Market Size (US$ Mn) Forecast, by Oncology Application, 2014–2024
  • Table 36 : Middle East & Africa Radiopharmaceutical Market Size (US$ Mn) Forecast, by End-user, 2014–2024
  • Figure 1 : Global Radiopharmaceutical Market Size (US$ Mn) Forecast, 2014–2024
  • Figure 2 : Market Value Share, by Radioisotope (2016)
  • Figure 3 : Market Value Share, by Source (2016)
  • Figure 4 : Market Value Share, by Application (2016)
  • Figure 5 : Market Value Share, by End-user (2016)
  • Figure 6 : Global Radiopharmaceutical Market Value Share Analysis, by Radioisotope, 2016 and 2024
  • Figure 7 : Global Technetium-99 Market Revenue
  • Figure 8 : Global Gallium-67 Market Revenue
  • Figure 9 : Global Iodine-123 Market Revenue
  • Figure 10 : Global 18F Market Revenue (US$ Mn),
  • Figure 11 : Global Rubidium-82 Market Revenue
  • Figure 12 : Global Yttrium-90 Market Revenue (US$ Mn), 2014–2024
  • Figure 13 : Global Lutetium-177 Market Revenue
  • Figure 14 : Global Iodine-125 Market Revenue (US$ Mn), 2014–2024
  • Figure 15 : Global Other Radioisotope Market Revenue (US$ Mn), 2014–2024
  • Figure 16 : Global Radiopharmaceutical Market Attractiveness Analysis, by Radioisotope, 2016-2024
  • Figure 17 : Global Radiopharmaceutical Market Value Share Analysis, by Source, 2016 and 2024
  • Figure 18 : Global Nuclear Reactor Market Revenue
  • Figure 19 : Global Cyclotrons Market Revenue (US$ Mn), 2014–2024
  • Figure 20 : Global Radiopharmaceutical Market Attractiveness Analysis, by Source 2016 and 2024
  • Figure 21 : Global Radiopharmaceutical Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 22 : Global Radiopharmaceutical Market Value Share Analysis, by Oncology Application, 2016 and 2024
  • Figure 23 : Global Cardiology Market Revenue
  • Figure 24 : Global Gastroenterology Market Revenue
  • Figure 25 : Global Oncology Market Revenue
  • Figure 26 : Global Nephrology Market Revenue (US$ Mn),
  • Figure 27 : Global Neurology Market Revenue
  • Figure 28 : Global Immunology Market Revenue (US$ Mn), 2014–2024
  • Figure 29 : Global Others Market Revenue (US$ Mn), 2014–2024
  • Figure 30 : Global Brachytherapy Market Revenue
  • Figure 31 : Global Others Market Revenue (US$ Mn), 2014–2024
  • Figure 32 : Global Radiopharmaceutical Market Attractiveness Analysis, by Application, 2016-2024
  • Figure 33 : Global Radiopharmaceutical Market Value Share Analysis, by End-user, 2016 and 2024
  • Figure 34 : Global Hospitals Market Revenue (US$ Mn), 2014–2024
  • Figure 35 : Global Ambulatory Surgical Center Market Revenue (US$ Mn), 2014–2024
  • Figure 36 : Global Diagnostic Centers Market Revenue
  • Figure 37 : Global Others Market Revenue (US$ Mn),
  • Figure 38 : Global Other End user Market Revenue
  • Figure 39 : Global Radiopharmaceutical Market Attractiveness Analysis, by End-user, 2016-2024
  • Figure 40 : Global Radiopharmaceutical Market Value Share Analysis, by Region, 2016 and 2024
  • Figure 41 : Global Radiopharmaceutical Market Attractiveness Analysis, by Region, 2016-2024
  • Figure 42 : North America Radiopharmaceutical Market Size
  • Figure 43 : North America Market Attractiveness Analysis,
  • Figure 44 : North America Market Value Share Analysis By Country, 2016 and 2024
  • Figure 45 : North America Market Value Share Analysis Source, 2016 and 2024
  • Figure 46 : North America Market Value Share Analysis by Source, 2016 and 2024
  • Figure 47 : North America Radiopharmaceuticals Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 48 : North America Radiopharmaceuticals Market Value Share Analysis, by Oncology Application, 2016 and 2024
  • Figure 49 : North America Market Value Share Analysis by End-user, 2016 and 2024
  • Figure 50 : North America Market Attractiveness Analysis by Radioisotope, 2016-2024
  • Figure 51 : North America Market Attractiveness Analysis by Source, 2016-2024
  • Figure 52 : North America Market Attractiveness Analysis by Application, 2016-2024
  • Figure 53 : North America Market Attractiveness Analysis by End –user, 2016-2024
  • Figure 54 : Europe Radiopharmaceutical Market Size (US$ Mn) Forecast, 2014–2024
  • Figure 55 : Europe Market Attractiveness Analysis, by Country, 2016–2024
  • Figure 56 : Europe Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 57 : Europe Market Value Share Analysis, by Radioisotope, 2016 and 2024
  • Figure 58 : Europe Market Value Share Analysis, by Source, 2016 and 2024
  • Figure 59 : Europe Radiopharmaceuticals Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 60 : Europe Radiopharmaceuticals Market Value Share Analysis, by Oncology Application, 2016 and 2024
  • Figure 61 : Europe Market Value Share Analysis, by End-user, 2016 and 2024
  • Figure 62 : North America Market Attractiveness Analysis by Radioisotope, 2016-2024
  • Figure 63 : North America Market Attractiveness Analysis by Source, 2016-2024
  • Figure 64 : North America Market Attractiveness Analysis by Application, 2016-2024
  • Figure 65 : North America Market Attractiveness Analysis by End –user, 2016-2024
  • Figure 66 : Asia Pacific Radiopharmaceutical Market Size
  • Figure 67 : Asia Pacific Radiopharmaceutical Market Attractiveness Analysis, by Country, 2016–2024
  • Figure 68 : Asia Pacific Radiopharmaceutical Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 69 : Asia Pacific Radiopharmaceutical Market Value Share Analysis, by Radioisotope, 2016 and 2024
  • Figure 70 : Asia Pacific Radiopharmaceutical Market Value Share Analysis, by Source, 2016 and 2024
  • Figure 71 : Asia Pacific Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 72 : Asia Pacific Market Value Share Analysis, by Oncology Application, 2016 and 2024
  • Figure 73 : Asia Pacific Radiopharmaceutical Market Value Share Analysis, by End-user, 2016 and 2024
  • Figure 74 : Asia Pacific Market Attractiveness Analysis by Radioisotope, 2016-2024
  • Figure 75 : Asia Pacific Market Attractiveness Analysis by Source, 2016-2024
  • Figure 76 : Asia Pacific Market Attractiveness Analysis by Application, 2016-2024
  • Figure 77 : Asia Pacific Market Attractiveness Analysis by End –user, 2016-2024
  • Figure 78 : Latin America Radiopharmaceutical Market Size (US$ Mn) Forecast, 2014–2024
  • Figure 79 : Latin America Market Attractiveness Analysis, by Country, 2016–2024
  • Figure 80 : Latin America Radiopharmaceutical Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 81 : Latin America Market Value Share Analysis, by Radioisotope, 2016 and 2024
  • Figure 82 : Latin America Market Value Share Analysis, by Source, 2016 and 2024
  • Figure 83 : Latin America Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 84 : Latin America Market Value Share Analysis, by Oncology Application, 2016 and 2024
  • Figure 85 : Latin America Market Value Share Analysis, by End-user, 2016 and 2024
  • Figure 86 : Latin America Market Attractiveness Analysis by Radioisotope, 2016-2024
  • Figure 87 : Latin America Market Attractiveness Analysis by Source, 2016-2024
  • Figure 88 : Latin America Market Attractiveness Analysis by Application, 2016-2024
  • Figure 89 : Latin America Market Attractiveness Analysis by End –user, 2016-2024
  • Figure 90 : Middle East & Africa Radiopharmaceutical Market Size (US$ Mn) Forecast, 2014–2024
  • Figure 91 : Middle East & Africa Radiopharmaceutical Market Attractiveness Analysis, by Country, 2016–2024
  • Figure 92 : Middle East & Africa Radiopharmaceutical Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 93 : Middle East & Africa Radiopharmaceutical Market Value Share Analysis, by Radioisotope, 2016 and 2024
  • Figure 94 : Middle East & Africa Market Value Share Analysis,
  • Figure 95 : Middle East and Africa Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 96 : Middle East and Africa Market Value Share Analysis, by Oncology Application, 2016 and 2024
  • Figure 97 : Middle East & Africa Radiopharmaceutical Market Value Share Analysis, by End-user, 2016 and 2024
  • Figure 98 : Middle East and Africa Market Attractiveness Analysis by Radioisotope, 2016-2024
  • Figure 99 : Middle East and Africa Market Attractiveness Analysis by Source, 2016-2024
  • Figure 100 : Middle East and Africa Market Attractiveness Analysis by Application, 2016-2024
  • Figure 101 : Middle East and Africa Market Attractiveness Analysis by End –user, 2016-2024
  • Figure 102 : Global Radiopharmaceutical Market Share Analysis, by Company (2015)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report